Background: As medicine grows increasingly technological and scientific, biomedical researchers working to bring new knowledge to bear on clinical practice face a key question: when is a new intervention or treatment ready for clinical use? Because this is both a technical and ethical dilemma, it is crucial to examine the social history of how different approaches to this question emerge and the values or assumptions they embed. Methods: We examine the rise and proliferation of an increasingly common framework for assessing the value of new biomedical data or technology, “actionability,” throu